Cargando…
The hard road to ranking the clinical benefit of antineoplastic agents: ESMO Award 2016 presentation
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
ESMO Open
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519818/ https://www.ncbi.nlm.nih.gov/pubmed/28761732 http://dx.doi.org/10.1136/esmoopen-2017-000157 |
| _version_ | 1783251701714649088 |
|---|---|
| author | Sobrero, Alberto |
| author_facet | Sobrero, Alberto |
| author_sort | Sobrero, Alberto |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5519818 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | ESMO Open |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-55198182017-07-31 The hard road to ranking the clinical benefit of antineoplastic agents: ESMO Award 2016 presentation Sobrero, Alberto ESMO Open Editorial ESMO Open 2017-03-09 /pmc/articles/PMC5519818/ /pubmed/28761732 http://dx.doi.org/10.1136/esmoopen-2017-000157 Text en © European Society for Medical Oncology (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| spellingShingle | Editorial Sobrero, Alberto The hard road to ranking the clinical benefit of antineoplastic agents: ESMO Award 2016 presentation |
| title | The hard road to ranking the clinical benefit of antineoplastic agents: ESMO Award 2016 presentation |
| title_full | The hard road to ranking the clinical benefit of antineoplastic agents: ESMO Award 2016 presentation |
| title_fullStr | The hard road to ranking the clinical benefit of antineoplastic agents: ESMO Award 2016 presentation |
| title_full_unstemmed | The hard road to ranking the clinical benefit of antineoplastic agents: ESMO Award 2016 presentation |
| title_short | The hard road to ranking the clinical benefit of antineoplastic agents: ESMO Award 2016 presentation |
| title_sort | hard road to ranking the clinical benefit of antineoplastic agents: esmo award 2016 presentation |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519818/ https://www.ncbi.nlm.nih.gov/pubmed/28761732 http://dx.doi.org/10.1136/esmoopen-2017-000157 |
| work_keys_str_mv | AT sobreroalberto thehardroadtorankingtheclinicalbenefitofantineoplasticagentsesmoaward2016presentation AT sobreroalberto hardroadtorankingtheclinicalbenefitofantineoplasticagentsesmoaward2016presentation |